Today’s news summary – Paper Talk 

Tuesday’s front pages report on wildfires across Europe amid extreme weather events happening around the world this month. 

The promising trial results for a new Alzheimer’s drug called donanemab leads several papers as it’s reported the drug could be available on the NHS by 2025. 

Alzheimer’s drug donanemab

The Times says the new drug could offer some people at least a year of extra time without their disease progressing. The Financial Times calls the trial results a watershed moment and says the pharmaceutical group Eli Lilly has submitted donanemab for approval by the US Food and Drug Administration and expects a decision this year, according to the paper. 

The Daily Mail cites charity estimates that more than 700,000 people could benefit, with the first patients being treated within 18 months. But the i newspaper points out that donanemab is not risk-free, reporting two people died during the trial from brain swelling – a common side effect which resolved in most cases. 

Plans to shut ticket offices

The Daily Mirror leads with five Labour mayors warning rail companies they will take legal action unless plans to shut nearly 1,000 ticket offices in England are scrapped. 

Ben Wallace’s comments are highlighted in the Daily Telegraph. He insists the UK must pay for more tanks – rather than troops – because budget constraints mean any extra soldiers would have to be armed “with pitchforks.”

The Times says a formal review of how the BBC is funded will be launched in the autumn amid concerns in the government that the current model is unsustainable.